Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Prepaid Assets: 2020-2025

Historic Prepaid Assets for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to $11.2 million.

  • Xeris Biopharma Holdings' Prepaid Assets rose 56.95% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 56.95%. This contributed to the annual value of $7.5 million for FY2024, which is 28.95% up from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Prepaid Assets stood at $11.2 million for Q3 2025, which was up 87.93% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Prepaid Assets ranged from a high of $11.2 million in Q3 2025 and a low of $3.6 million during Q3 2021.
  • Over the past 3 years, Xeris Biopharma Holdings' median Prepaid Assets value was $7.5 million (recorded in 2024), while the average stood at $7.8 million.
  • Per our database at Business Quant, Xeris Biopharma Holdings' Prepaid Assets spiked by 119.07% in 2022 and then crashed by 37.78% in 2023.
  • Xeris Biopharma Holdings' Prepaid Assets (Quarterly) stood at $4.6 million in 2021, then soared by 102.38% to $9.3 million in 2022, then tumbled by 37.78% to $5.8 million in 2023, then rose by 28.95% to $7.5 million in 2024, then surged by 56.95% to $11.2 million in 2025.
  • Its last three reported values are $11.2 million in Q3 2025, $6.0 million for Q2 2025, and $6.0 million during Q1 2025.